15
Participants
Start Date
November 17, 1998
Primary Completion Date
April 19, 2000
Study Completion Date
May 27, 2003
Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
cG250 is an IgG1 chimeric monoclonal antibody. It was supplied as a sterile solution at a concentration of 1.0 mg/mL in either a 2 mL or a 5 mL vial. cG250 was radiolabeled with Iodine-131 prior to use.
Memorial Sloan-Kettering Cancer Center, New York
Lead Sponsor
National Cancer Institute (NCI)
NIH
Ludwig Institute for Cancer Research
OTHER